Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,726 public trials 586 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Active, Not Recruiting

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

NCT05186753

Conditions
BMM, Bone Marrow Mastocytosis, Hematologic Diseases, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • One of a Kind Clinical Research Center Scottsdale, Arizona, United States
  • Modena Allergy and Asthma Clinical La Jolla, California, United States
View all 57 locations
View Trial Details
Active, Not Recruiting

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

NCT04541108

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +23 more
Locations
  • LSU Health Sciences Center - Shreveport Shreveport, Louisiana, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • UC Health Cincinnati, Ohio, United States
View Trial Details
Active, Not Recruiting

Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients

NCT03643133

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +4 more
Locations
  • CHU Amiens-Picardie - Service d'oncologie hématologie pédiatrique Amiens, France
  • CHU d'Angers - Service d'oncologie pédiatrique Angers, France
  • Institut Bergonié - Service d'oncologie médicale Bordeaux, France
  • CHU de Caen - Service d'oncologie hématologie pédiatrique Caen, France
View all 31 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

NCT05691504

Conditions
Adnexal Diseases, Advanced Endometrial Carcinoma, Carcinosarcoma, +28 more
Locations
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Active, Not Recruiting

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

NCT05694871

Conditions
Advanced Dedifferentiated Liposarcoma, Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
View all 194 locations
View Trial Details

Related conditions